Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Meet Our Editor-in-Chief
Volume: 18 Issue: 1
Author(s): Ryuichi Morishita
Affiliation:
Export Options
About this article
Cite this article as:
Morishita Ryuichi , Meet Our Editor-in-Chief, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2018; 18 (1) . https://dx.doi.org/10.2174/187152221801180905151147
DOI https://dx.doi.org/10.2174/187152221801180905151147 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
24
2
2
Related Articles
-
Bis-Quinolinium Cyclophanes: Highly Potent and Selective Non-Peptidic Blockers of the Apamin-Sensitive Ca2+-Activated K+ Channel
Current Medicinal Chemistry HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research Effects of Melatonin Derivatives on Human Malaria Parasite Plasmodium falciparum
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) L-/N-type Calcium Channel Blockers and Proteinuria
Current Hypertension Reviews The Gut Microbiome, Lactobacillus acidophilus; Relation with Type 2 Diabetes Mellitus
Current Diabetes Reviews Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran
Infectious Disorders - Drug Targets A New Binding Site Involving the C-terminal Domain to Design Specific Inhibitors of PepX
Protein & Peptide Letters Withanolides: Biologically Active Constituents in the Treatment of Alzheimer’s Disease
Medicinal Chemistry Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science Preventative and Therapeutic Potential of Lipopolysaccharide Derived from Edible Gram-Negative Bacteria to Various Diseases
Current Drug Therapy Adipocytokines; Cause for Metabolic Syndrome
Current Medicinal Chemistry - Central Nervous System Agents Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects
Current Bioinformatics Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
Current Pharmaceutical Design Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Cardiac Dysfunction and Oxidative Stress in the Metabolic Syndrome: an Update on Antioxidant Therapies
Current Pharmaceutical Design Immune-Neuroendocrine Dysregulation in Patients with Osteoarthritis: A Revision and a Pilot Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Identification of New Susceptibility Genes for Type 1 Diabetes: An Update
Current Immunology Reviews (Discontinued) Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Editorial [Hot topic:Pigment Epithelium-Derived Factor (PEDF) in Health and Disease (Guest Editor: Sho-Ichi Yamagishi)]
Current Molecular Medicine